Glycoprotein Defects Responsible for Abnormal Platelet Function in Inherited Platelet Disorders

  • Alan T. Nurden


The study of congenital bleeding syndromes has yielded much information on how normal platelets function. In particular, the characterization of the molecular defects in disorders of platelet adhesion and aggregation has resulted in specific roles being proposed for different membrane glycoproteins and α-granule proteins in these processes. In this chapter, we will highlight three major inherited disorders of platelet function: Bemard-Soulier syndrome (BSS), gray platelet syndrome (GPS), and Glanzmann’s thrombasthenia (GT). Each disorder will be introduced by a brief description of the platelet function abnormalities present. This will be followed by a detailed discussion of the specific molecular defects that distinguish the platelets of each syndrome. Emphasis will be placed on reviewing recent data, although an attempt will be made to interpret previous studies in the context of the new advances. Where possible, the different molecular abnormalities will be assessed in terms of how their presence leads to modifications of platelet adhesion and aggregation mechanisms in hemostasis.


Platelet Glycoprotein Normal Platelet Clot Retraction Disulfide Reduction Platelet Membrane Glycoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ames, G. F., and Nikaido, K., 1976, Two-dimensional gel electrophoresis of membrane proteins, Biochemistry 15:616–623.PubMedCrossRefGoogle Scholar
  2. Baumgartner, H. R., 1973, The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi, Microvasc. Res. 5:161–179.CrossRefGoogle Scholar
  3. Baumgartner, H. R., Tschopp, T. B., and Weiss, H. J., 1977, Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium, Thromb, Haemostasis. 37:17–28.Google Scholar
  4. Bauvois, B., Cartron, J. P., Nurden, A., and Caen, J. P., 1981, Glycoprotein-sialyltransferase activity of normal human, thrombasthenic, and Bemard-Soulier platelets, Vox Sang. 40:71–78.PubMedCrossRefGoogle Scholar
  5. Belloc, F., Hourdille, P., Fialon, P., Boisseau, M. R., and Soria, J., 1983, Fibrinogen synthesis by isolated human megakaryocytes, Thromb. Haemostasis 50:18a.Google Scholar
  6. Bellucci, S., Tobelem, G., and Caen, J. P., 1983, Inherited platelet disorders, Prog. Hematol. 13:223–264.PubMedGoogle Scholar
  7. Bennett, J. S., and Vilaire, G., 1979, Exposure of platelet fibrinogen receptors by ADP and epinephrine, J. Clin. Invest. 64:1393–1401.PubMedCrossRefGoogle Scholar
  8. Bennett, J. S., Vilaire, G., and Cines, D. B., 1982, Identification of the fibrinogen receptor on human platelets by photoaffinity labeling, J. Biol. Chem. 257:8049–8054.PubMedGoogle Scholar
  9. Berndt, M. C., and Phillips, D. R., 1981, Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V, J. Biol. Chem. 256:59–65.PubMedGoogle Scholar
  10. Berndt, M. C., Gregory, C., Chong, B. H., Zola, H., and Castaldi, P. 1983, Additional glycoprotein defects in Bemard-Soulier syndrome: Confirmation of genetic basis by parental analysis, Blood 62:800–807.PubMedGoogle Scholar
  11. Bithell, T. C., Parekh, S. J., and Strong, R. R., 1972, Platelet-function studies in the Bemard-Soulier syndrome, Ann. N.Y. Acad. Sci. 201:145–160.PubMedCrossRefGoogle Scholar
  12. Brass, L. F., and Shattil, S. J., 1984, Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets, J. Clin. Invest. 73:626–632.PubMedCrossRefGoogle Scholar
  13. Breton-Gorius, J., Vainchenker, W., Nurden, A., Levy-Toledano, S., and Caen, J., 1981, Defective a- granule production in megakaryocytes from gray platelet syndrome. Ultrastmctural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors, Am. J. Pathol. 102:10–19.PubMedGoogle Scholar
  14. Caen, J. P., 1972, Glanzmann’s thrombasthenia, Clin. Haematol 1:383–392.Google Scholar
  15. Caen, J. P., and Nurden, A. T., 1983, Inherited abnormalities of platelet glycoproteins, Surv. Synth. Pathol. Res. 1:274–281.Google Scholar
  16. Caen, J. P., Castaldi, P. A., Leclerc, J. C., Inceman, S., Larrieu, M. J., Probst, M., and Bernard, J., 1966, Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann’s thrombasthenia (report of fifteen patients), Am. J. Med. 41:4–26.CrossRefGoogle Scholar
  17. Caen, J. P., Nurden, A. T., Jeanneau, C., Michel, H., Tobelem, G., Levy-Toledano, S., Sultan, Y., Valensi, F., and Bernard, J., 1976, Bemard-Soulier syndrome. A new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein, J. Lab. Clin. Med. 87:586–596.PubMedGoogle Scholar
  18. Caen, J. P., Rosa, J-P., Boizard, B., and Nurden, A. T., 1983, Thrombasthenia Paris I variant, a model for the study of the platelet (GP) Ilb-IIIa complex, Blood 62:25a.Google Scholar
  19. Cartron, J. P., and Nurden, A. T., 1979, Galactosyltransferase and membrane glycoprotein abnormality in human platelets from Tn-syndrome donors. Nature (London) 282:621–623.CrossRefGoogle Scholar
  20. Castaldi, P., and Caen, J. P., 1965, Platelet fibrinogen, J. Clin. Pathol. 18:579–585.PubMedCrossRefGoogle Scholar
  21. Chediak, J., Telfer, M. C., van der Laan, B., Maxey, B., and Cohen, I., 1979, Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic platelets, Br. J. Haematol. 43:113–126.PubMedCrossRefGoogle Scholar
  22. Clemetson, K. J., Capitanio, A, Pareti, F. I., McGregor, J. L., and Luscher, E. F., 1980, Additional platelet membrane glycoprotein abnormalities in Glanzmann’s thrombasthenia: A comparison with normals by high resolution two-dimensional Polyacrylamide gel electrophoresis, Thromb. Res. 18:797–806.PubMedCrossRefGoogle Scholar
  23. Clemetson, K. J., Naim, H. Y., and Luscher, E. F., 1981a, Relationship between glycocalicin and glycoprotein lb of human platelets, Proc. Natl. Acad. Sci. U.S.A. 78:2712–2716.PubMedCrossRefGoogle Scholar
  24. Clemetson, K. J., McGregor, J. L., James, E., Dechavanne, M., and Luscher, E. F., 1981b, Membrane glycoprotein defects in Bemard-Soulier syndrome platelets, Thromb. Haemostasis 46:108a.Google Scholar
  25. Clemetson, K. J., McGregor, J. L., James, E., Dechavanne, M., and Luscher, E. F., 1982, Characterization of the platelet membrane glycoprotein abnormalities in Bemard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis, J. Clin. Invest. 70:304–311.PubMedCrossRefGoogle Scholar
  26. Coller, B. S., 1978, The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility, J. Clin. Invest. 61:1168–1175.PubMedCrossRefGoogle Scholar
  27. Coller, B. S., Peerschke, E. L, Scudder, L. E., and Sullivan, C. A., 1983a, Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GP lb as a platelet receptor for von Willebrand factor, Blood 61:99–110.PubMedGoogle Scholar
  28. Coller, B. S., Peerschke, E. L, Scudder, L. E., and Sullivan, C. A., 1983b, A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins lib and/or Ilia, J. Clin. Invest. 72:325–338.PubMedCrossRefGoogle Scholar
  29. Coller, B. S., Peerschke, E. L, Nurden, A. T., and Rosa, J-P., 1983c, The epitope of a monoclonal antibody that inhibits fibrinogen binding to platelets is EDTA-sensitive: Implications for the presence of the GP Ilb/IIIa complex on unactivated platelets, Thromb. Haemostasis 50:314a.Google Scholar
  30. Degos, L., Tobelem, G., Lethielleux, P., Levy-Toledano, S., Caen, J., and Colombani, J., 1977, Molecular defect in platelets from patients with Bemard-Soulier syndrome, Blood 50:899–903.PubMedGoogle Scholar
  31. Donati, M. B., Balconi, G., Remuzzi, G., Borgia, R., Morasco, L., and de Gaetano, G., 1977, Skin fibroblasts from a patient with Glanzmann’s thrombasthenia do not induce fibrin clot retraction, Thromb. Res. 10:173–174.PubMedCrossRefGoogle Scholar
  32. Drouin, J., Wong, S. C., Jamieson, G. A., and Rock, G. A., 1980, Release of ATP and serotonin from Bemard-Soulier platelets in response to various aggregating agents, in: 18th Congress of the International Society of Hematology (Abstracts), Montreal, p. 219a.Google Scholar
  33. Evensen, S. A., Solum, N. O., Grottum, K. A., and Hovig, T., 1974, Familial bleeding disorder with a moderate thrombocytopenia and giant platelets, Scand. J. Haematol. 13:203–214.PubMedCrossRefGoogle Scholar
  34. Gartner, T. K., Gerrard, J. M., White, J. G., and Williams, D. C., 1981, The endogenous lectin of human platelets is an a-granule component, Blood 58:153–157.PubMedGoogle Scholar
  35. George, J. N., Reimann, T. A., Moake, J. L., Morgan, R. K., Cimo, P. L., and Sears, D. A., 1981, Bemard-Soulier disease: A study of four patients and their parents, Br. J. Haematol. 48:459–467.PubMedCrossRefGoogle Scholar
  36. George, J. N., Nurden, A. T., and Phillips, D. R., 1984, Molecular defects in interactions of platelets with the vessel wall, New Engl. J. Med. 311:1084–1098.PubMedCrossRefGoogle Scholar
  37. Gerrard, J. M., and White, J. G., 1976, The influence of aspirin and indomethacin on the platelet contractile wave, Am. J. Pathol. 82:513–526.PubMedGoogle Scholar
  38. Gerrard, J. M., Schollmeyer, J. V., Phillips, D. R., and White, J. G., 1979, α-Actinin deficiency in thrombasthenia, Am. J. Pathol. 94:509–528.PubMedGoogle Scholar
  39. Gerrard, J. M., Phillips, D. R., Rao, G. H. R., Plow, E. F., Waltz, D. A., Ross, R., Marker, L. A., and White, J. G., 1980, Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules, J. Clin. Invest. 66:102–109.PubMedCrossRefGoogle Scholar
  40. Ginsberg, M. H., Forsyth, J., Lightsey, A., Chediak, J., and Plow, E. F., 1983, Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets, J. Clin. Invest. 71:619–624.PubMedCrossRefGoogle Scholar
  41. Gogstad, G. O., Hägen, I., Korsmo, R., and Solum, N. O., 1981, Characterization of the proteins of isolated human platelet a-granules. Evidence for a separate a-granule pool of the glycoproteins IIb and Ilia, Biochim. Biophys. Acta 670:150–162.PubMedGoogle Scholar
  42. Gogstad, G. O., Kmtnes, M-B., and Solum, N. O., 1983, Calcium-binding proteins from human platelets. A study using crossed Immunoelectrophoresis and 45Ca2+, Eur. J. Biochem. 133:193–199.PubMedCrossRefGoogle Scholar
  43. Grottum, K. A., and Solum, N. O., 1969, Congenital thrombocytopenia with giant platelets: A defect in the platelet membrane, Br. J. Haematol 16:277–290.PubMedCrossRefGoogle Scholar
  44. Hagen, L, and Solum, N. O., 1978, Further studies on the protein composition and surface structure of normal platelets and platelets from patients with Glanzmann’s thrombasthenia and Bemard-Soulier syndrome, Thromb. Res. 13:845–855.PubMedCrossRefGoogle Scholar
  45. Hägen, I., Nurden, A., Bjerrum, O. J., Solum, N. O., and Caen, J. P., 1980, Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann’s thrombasthenia and Bemard-Soulier syndrome, J. Clin. Invest. 65:722–731.PubMedCrossRefGoogle Scholar
  46. Heptinstall, S., Burgess-Wilson, M., Cockbill, S. R., Fox, S. C., and Sills, T., 1983, Platelet aggregation in whole blood. Studies in normal subjects and in Glanzmann’s thrombasthenia, Thromb. Haemostasis 50:216a.Google Scholar
  47. Herrmann, F. H., Meyer, M., and Ihle, E., 1982, Protein and glycoprotein abnormalities in an unusual subtype of Glanzmann’s thrombasthenia, Haemostasis 12:337–344.PubMedGoogle Scholar
  48. Holahan, J. R., and White, G. C., 1981, Heterogeneity of membrane surface proteins in Glanzmann’s thrombasthenia, Blood 57:174–181.PubMedGoogle Scholar
  49. Holmsen, H., and Weiss, H. J., 1979, Secretable storage pools in platelets, Annu. Rev. Med. 30:119–134.PubMedCrossRefGoogle Scholar
  50. Hourdille, P., Hasitz, M., Belloc, F., and Nurden, A. T., 1984, Immunocytochemical study of the binding of fibrinogen and thrombospondin to ADP- and thrombin-stimulated human platelets. Blood (in press).Google Scholar
  51. Howard, M. A., Hutton, R. A., and Hardisty, R. M., 1973, Hereditary giant platelet syndrome: A disorder of a new aspect of platelet function, Br. Med. J. 4:586–588.CrossRefGoogle Scholar
  52. Howard, M. A., Montgomery, D. C., and Hardisty, R. M., 1974, Factor-Vlll-related antigen in platelets, Thromb. Res. 4:617–624.PubMedCrossRefGoogle Scholar
  53. Jackson, D. P., Morse, E. E., Zieve, P. D., and Conley, C. L., 1963, Thrombocytopenic purpura associated with defective clot retraction and absence of platelet fibrinogen, Blood 22:827a.Google Scholar
  54. Jaffe, E. A., Leung, L. L. K., Nachman, R. L., Levin, R. L, and Mosher, D. F., 1982, Thrombospondin is the endogenous lectin of human platelets, Nature (London) 295:246–248.CrossRefGoogle Scholar
  55. Jamieson, G. A., and Okumura, T., 1978, Reduced thrombin binding and aggregation in Bemard-Soulier platelets, J. Clin. Invest. 61:861–864.PubMedCrossRefGoogle Scholar
  56. Jamieson, G. A., Okumura, T., Fishback, B., Johnson, M. M., Egan, J. J., and Weiss H. J., 1979, Platelet membrane glycoproteins in thrombasthenia, Bemard-Soulier syndrome, and storage pool disease, J. Lab. Clin. Med. 93:652–660.PubMedGoogle Scholar
  57. Jenkins, C. S. P., Phillips, D. R., Clemetson, K. J., Meyer, D., Larrieu M-J., and Luscher, E. F., 1976, Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bemard-Soulier syndrome and von Willebrand’s disease, J. Clin. Invest. 57:112–124.PubMedCrossRefGoogle Scholar
  58. Johnston, G. L, Taylor, P. M., and Heptinstall, S., 1983, Studies on platelets from patients with Glanzmann’s thrombasthenia suggest that the surface located Ca-binding sites that are relevant to platelet aggregation are associated with glycoproteins lib and Ilia, Thromb.Haemostasis 50:215a.Google Scholar
  59. Kao, K. J., Pizzo, S. V., and McKee, P. A., 1979, Demonstration and characterization of specific binding sites for Factor Vlll/von Willebrand factor on human platelets, J. Clin. Invest. 63:656–664.PubMedCrossRefGoogle Scholar
  60. Kirby, E. P., 1982, The agglutination of human platelets by bovine factor VIII:R, J. Lab. Clin. Med. 100:963–976.PubMedGoogle Scholar
  61. Komecki, E., Niewiarowski, S., Morinelli, T. A., and Kloczewiak, M., 1981, Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann’s thrombasthenic platelets, J. Biol. Chem. 256:5696–5701.Google Scholar
  62. Komecki, E., Tuszynski, G. P., and Niewiarowski, S., 1983, Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein Illa, J. Biol. Chem. 258:9349–9356.Google Scholar
  63. Kunicki, T. J., and Aster, R. H., 1978, Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann’s thrombasthenia, J. Clin. Invest. 61:1225–1231.PubMedCrossRefGoogle Scholar
  64. Kunicki, T. J., Pidard, D., Rosa, J-P., and Nurden, A. T., 1981a, The formation of Ca2+-dependent complexes of platelet membrane glycoproteins lib and Ilia in solution as determined by crossed Immunoelectrophoresis, Blood 58:268–278.PubMedGoogle Scholar
  65. Kunicki, T. J., Nurden, A. T., Pidard, D., Russell, N. R., and Caen, J. P., 1981b, Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed immunoelectrophoresis, Blood 58:1190–1197.PubMedGoogle Scholar
  66. Kunicki, T. J., Pidard, D., Cazenave, J-P., Nurden, A. T., and Caen, J. P., 1981c, Inheritance of the human platelet alloantigen, PlA1 in type I Glanzmann’s thrombasthenia, Clin, Invest. 67:717–724.CrossRefGoogle Scholar
  67. Lahav, J., Schwartz, M. A., Hynes, R. O., 1982, Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: Interaction of thrombospondin with fibronectin and collagen, Cell 31:253–262.PubMedCrossRefGoogle Scholar
  68. Lee, H., Nurden, A. T., Thomaidis, A., and Caen, J. P., 1981, Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann’s thrombasthenia type I and type II, Br. J. Haematol. 48:47–57.PubMedCrossRefGoogle Scholar
  69. Levy-Toledano, S., Maclouf, J., Rendu, F., Rigaud, M., and Caen, J. P., 1979, lonophore A23187 and thrombasthenic platelets: A model for dissociating serotonin release and thromboxane formation from true aggregation, Thromb. Res. 16:453–462.PubMedCrossRefGoogle Scholar
  70. Levy-Toledano, S., Caen, J. P., Breton-Gorius, J., Rendu, F., Cywiner-Golenzer, C., Dupuy, E., Legrand, Y., and Maclouf, J., 1981, Gray platelet syndrome: a-granule deficiency. Its influence on platelet function, J. Lab. Clin. Med. 98:831–848.PubMedGoogle Scholar
  71. Lightsey, A. L., Plow, E. F., McMillan, R., and Ginsberg, M. H., 1981, Glanzmann’s thrombasthenia in the absence of GP lib and III deficiency.Blood 58(suppl):199a.Google Scholar
  72. Malmsten, C., Kindahl, H., Samuelsson, B., Levy-Toledano, S., Tobelem, G., and Caen, J. P., 1977, Thromboxane synthesis and the platelet release reaction in Bemard-Soulier, Glanzmann’s thrombasthenia and Hermansky-Pudlak syndrome, Br. J. Haematol 35:511–520.PubMedCrossRefGoogle Scholar
  73. McEver, R. P., Baenziger, N. L., and Majerus, P. W., 1980, Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody, J. Clin Invest. 66:1311–1318.PubMedCrossRefGoogle Scholar
  74. McEver, R. P., Bennett, E. M., and Martin, M. N., 1983, Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein lib—Ilia using monoclonal antibodies, J. Biol. Chem. 258:5269–5275.PubMedGoogle Scholar
  75. McGill, M., Jamieson, G. A., Drouin, J., and Rock, G. A., 1980, Size and shape of Bemard-Soulier platelets in native and anticoagulated blood, in: 18th Congress of the International Society of Hematology (Abstracts), Montreal, p. 219a.Google Scholar
  76. McGregor, J. L., Clemetson, K. J., James, E., Luscher, E. F., and Dechavanne, M., 1980, A comparison of the major platelet membrane glycoproteins from Bemard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues, Thromb. Res. 17:713–718.PubMedCrossRefGoogle Scholar
  77. McGregor, J. L., Clemetson, K. J., James E., Capitanio, A., Greenland, T., Luscher, E. F., and Dechavanne, M., 1981, Glycoproteins of platelet membranes from Glanzmann’s thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and highresolution two-dimensional gel electrophoresis, Eur. J. Biochem. 116:379–388.PubMedCrossRefGoogle Scholar
  78. McMichael, A. J., Rust, N. A., Pilch, J. R., Sochynsky, R., Morton, J., Mason, D. Y., Ruan, C., Tobelem, G., and Caen, J., 1981, Monoclonal antibody to human platelet glycoprotein LI. Immunological studies, Br. J. Haematol. 49:501–509.PubMedCrossRefGoogle Scholar
  79. Meyer, D., and Baumgartner, H. R., 1983, Role of von Willebrand factor in platelet adhesion to the subendothelium, Br. J. Haematol. 54:1–9.PubMedCrossRefGoogle Scholar
  80. Moake, J. L., Olson, J. D., Troll, J. H., Tang, S. S., Funicella, T., and Peterson, D. M., 1980, Binding of radioiodinated human von Willebrand factor to Bemard-Soulier, thrombasthenic and von Willebrand’s disease platelets, Thromb. Res. 19:21–27.PubMedCrossRefGoogle Scholar
  81. Montgomery, R. R., .Kunicki, T. J., Taves, C., Pidard, D., and Corcoran, M., 1983, Diagnosis of Bemard-Soulier syndrome and Glanzmann’s thrombasthenia with a monoclonal assay on whole blood, J. Clin. Invest. 71:385–389.PubMedCrossRefGoogle Scholar
  82. Mustard, J. F., Kinlough-Rathbone, R. L., Packham, M. A., Perry, D. W., Harfenist, E. J., and Pai, K. R. M., 1979, Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin, Blood 54:987–993.PubMedGoogle Scholar
  83. Nachman, R. L., Levine, R. F., and Jaffe, E. A., 1977, Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes, J. Clin. Invest. 60:914–921.PubMedCrossRefGoogle Scholar
  84. Nibu, K., Ideguchi, H., and Hamasaki, N., 1982, Platelet glycoproteins of Bemard-Soulier syndrome: Analysis by isoelectric focusing and sodium dodecyl sulfate Polyacrylamide gel electrophoresis in a two-dimensional technique, Thromb. Res. 28:67–74.PubMedCrossRefGoogle Scholar
  85. Niewiarowski, S., Budzynski, A. Z., Morinelli, T. A., Bmdzynski, T. M., and Stewart, G. J., 1981, Exposure of fibrinogen receptors on human platelets by proteolytic enzymes, J. Biol Chem. 256:917–925.Google Scholar
  86. Nurden, A. T., and Caen, J. P., 1974, An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia, Br. J. Haematol. 28:253–260.PubMedCrossRefGoogle Scholar
  87. Nurden, A. T., and Caen, J. P., 1975, Specific roles for platelet surface glycoproteins in platelet function, Nature (London) 255:720–722.CrossRefGoogle Scholar
  88. Nurden, A. T., and Caen, J. P., 1979, The different glycoprotein abnormalities in thrombasthenic and Bemard-Soulier platelets, Semin. Hematol. 16:234–250.PubMedGoogle Scholar
  89. Nurden, A. T., and Dupuis, D., 1981, The reduced aggregation response of Bemard-Soulier platelets to thrombin may be related to an abnormal glycoprotein V, Thromb. Haemostasis 46:216a.Google Scholar
  90. Nurden, A. T., Dupuis, D., Kunicki, T. J., and Caen, J. P., 1981a, Analysis of the glycoprotein and protein composition of Bemard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis, J. Clin. Invest. 67:1431–1440.PubMedCrossRefGoogle Scholar
  91. Nurden, A. T., Dupuis, D., Pidard, D., Kunicki, T., and Caen, J. P., 1981b, Biochemistry and immu-nology of platelet membranes with reference to glycoprotein composition, Ann. N.Y. Acad. Sci. 370:72–86.PubMedCrossRefGoogle Scholar
  92. Nurden, A. T., Kunicki, T. J., Dupuis, D., Soria, C., and Caen, J. P., 1982a, Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome, Blood 59:709–718.PubMedGoogle Scholar
  93. Nurden, A. T., Dupuis, D., Pidard, D., Kieffer, N., Kunicki, T. J., and Cartron, J-P., 1982b, Surface modifications in the platelets of a patient with a-N-Acetyl-D-Galactosamine residues, the Tn-syndrome, J. Clin. Invest. 70:1281–1291.PubMedCrossRefGoogle Scholar
  94. Nurden, A. T., Didry, D., and Rosa, J-P., 1983a, Molecular defects of platelets in the Bemard-Soulier syndrome, Blood Cells 9:333–358.PubMedGoogle Scholar
  95. Nurden, A. T., Rosa, J-P., Boizard, B., Didry, D., Legrand, C. and Parquet, A., 1983b, Evidence that GP Ilb-IIIa complexes are required for ADP-induced platelet aggregation. Studies on the platelets of a patient with a new type of Glanzmann’s thrombasthenia, Thromb. Haemostasis 50:216a.Google Scholar
  96. O’Farrell, P. H., 1975, High resolution two-dimensional electrophoresis of proteins, J. Biol. Chem. 250:4007–4021.PubMedGoogle Scholar
  97. Peerschke, E. L, Zucker, M. B., Grant, R. A., Egan, J. J., and Johnson, M. M., 1980a, Correlation between fibrinogen binding to human platelets and platelet aggregability, Blood 55:841–847.PubMedGoogle Scholar
  98. Peerschke, E. I., Grant, R. A., and Zucker, M. B., 1980b, Decreased association of 45calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation, Br. J. Haematol.46:247–256.PubMedCrossRefGoogle Scholar
  99. Peterson, D. M., and Wehring, B., 1981, Isoelectric characteristics and surface radioiodination of normal and thrombasthenic platelet membrane glycoproteins, Thromb. Res. 22:53–65.PubMedCrossRefGoogle Scholar
  100. Peterson, D. M., Hirst, A., and Wehring, B., 1982, Comparison of normal and Bemard-Soulier platelet membrane glycoproteins. Isoelectric characteristics and surface radiolabel, J. Lab. Clin. Med. 100:26–36.PubMedGoogle Scholar
  101. Phillips, D. R., and Poh Agin, P., 1977a, Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis, J. Biol. Chem. 252:2120–2126.Google Scholar
  102. Phillips, D. R., and Poh Agin, P., 1977b, Platelet membrane defects in Glanzmann’s thrombasthenia, J. Clin. Invest. 60:535–545.PubMedCrossRefGoogle Scholar
  103. Phillips, D. R., Jenkins, C. S. P., Luscher, E. F., and Larrieu, M-J., 1975, Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature (London) 257:599–600.CrossRefGoogle Scholar
  104. Pidard, D., Montgomery, R. R., Bennett, J. S., and Kunicki, T. J., 1983, Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein Ilb-IIIa complex, with intact platelets, J. Biol. Chem. 258:12582–12586.PubMedGoogle Scholar
  105. Plow, E. F., Srouji, A. H., Meyer, D., Marguerie, G., and Ginsberg, M. H., 1984, Evidence that three adhesive proteins interact with a common recognition site on activated platelets, J. Biol. Chem. 259:5388–5391.PubMedGoogle Scholar
  106. Rendu, F., Nurden, A. T., Lebret, M., and Caen, J. P., 1981, Further investigations on Bemard-Soulier platelet abnormalities. A study of 5-hydroxytryptamine uptake and mepacrine fluorescence, J. Lab. Clin. Med. 97:689–699.PubMedGoogle Scholar
  107. Rosa, J.-P., Kieffer, N., Didry, D., Pidard, D., Kunicki, T. J., and Nurden, A. T., 1984, The human platelet membrane glycoprotein complex GP Ilb-IIIa expresses antigenic sites not exposed on the dissociated glycoproteins, Blood 64:1246–1253.PubMedGoogle Scholar
  108. Rosenstein, R., Zacharski, L. R., and Allen, R. D., 1981, Quantitation of human platelet transformation on siliconized glass: Comparison of "normal" and "abnormal" platelets, Thromb. Haemostas, 46:521–524.Google Scholar
  109. Ruan, C., Tobelem, G., McMichael, A. J., Drouet, L., Legrand, Y., Degos, L., Kieffer, N., Lee, H., and Caen, J. P., 1981, Monoclonal antibody to human platelet glycoprotein L IL Effects on human platelet function, Br. J. Haematol. 49:511–519.PubMedCrossRefGoogle Scholar
  110. Ruggeri, Z. M., Bader, R., and De Marco, L., 1982, Glanzmann’s thrombasthenia: Deficient binding of von Willebrand factor to thrombin-stimulated platelets, Proc. Natl. Acad. Sci. U.S.A. 79:6038–6041.PubMedCrossRefGoogle Scholar
  111. Ruggeri, Z. M., De Marco, L., Gatti, L., Bader, R., and Montgomery, R. R., 1983, Platelets have more than one binding site for von Willebrand factor, J. Clin, Invest. 72:1–12.CrossRefGoogle Scholar
  112. Ryo, R., Nakeff, A., Huang, S. S., Ginsberg, M., and Deuel, T. F., 1983, New synthesis of a plateletspecific protein: Platelet factor 4 synthesis in a megakaryocyte-enriched rabbit bone marrow culture system, J. Cell. Biol. 96:515–520.PubMedCrossRefGoogle Scholar
  113. Shulman, S., and Karpatkin, S., 1980, Crossed Immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann’s thrombasthenia and Bemard-Soulier syndrome, J. Biol. Chem. 255:4320–4327.PubMedGoogle Scholar
  114. Shulman, S., Wiesner, R., Troll, W., and Karpatkin, S., 1983, Re-evaluation of the presence of the major antigen Ca++ complex in Bemard-Soulier syndrome platelets. Elastase degradation of the complex in Bemard-Soulier syndrome platelet preparations, Thromb. Res. 30:61–69.PubMedCrossRefGoogle Scholar
  115. Solum, N. O., Hägen, L, and Gjemdal, T., 1977, Platelet membrane glycoproteins and the interaction between bovine factor VIII related protein and human platelets, Throm. Res. 38:914–923.Google Scholar
  116. Stormorken, H., Gogstad, G. O., Solum, N. O., and Pande, H., 1982, Diagnosis of heterozygotes in Glanzmann’s thrombasthenia, Thromb. Haemostasis 48:217–221.Google Scholar
  117. Tobelem, G., Levy-Toledano, S., Bredoux, R., Michel, H., Nurden, A., Caen, J. P., and Degos, L., 1976, New approach to determination of specific functions of platelet membrane sites, Nature (London) 263:427–429.CrossRefGoogle Scholar
  118. Tschopp, T. B., Weiss, H. J., and Baumgartner, H. R., 1975, Interaction of thrombasthenic platelets with subendothelium, normal adhesion, absent aggregation, Experientia 31:113–117.PubMedCrossRefGoogle Scholar
  119. Van Leeuwen, E. F., van dem Bome, A. E. G. K., von Riesz, L. E., Nijenhuis, L. E., and Engelfriet, C. P., 1981, Absence of platelet-specific alloantigens in Glanzmann’s thrombasthenia, Blood 57:49–59.PubMedGoogle Scholar
  120. Walsh, P. N., Mills, D. C. B., Pareti, F. L, Stewart, G. J., Macfarlane, D. E., Johnson, M. M., and Egan, J. J., 1975, Hereditary giant-platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor XI binding to platelets, Br. J. Haematol. 29:639–655.PubMedCrossRefGoogle Scholar
  121. Weiss, H. J., Tschopp, T. B., Baumgartner, H. R., Sussman, I. L, Johnson, M. M., and Egan, J. J., 1974, Decreased adhesion of giant (Bemard-Soulier) platelets to subendothelium—further implications on the role of the von Willebrand factor in hemostasis. Am. J. Med. 57:920–925.PubMedCrossRefGoogle Scholar
  122. Weiss, H. J., Turitto, V. T., and Baumgartner, H. R., 1978, Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. 1. Shear rate-dependent decrease of adhesion in von Willebrand’s disease and the Bemard-Soulier syndrome, J. Lab. Clin. Med. 92:750–764.PubMedGoogle Scholar
  123. White, J. G., 1979, Ultrastmctural studies of the gray platelet syndrome, Am. J. Pathol. 95:445–462.PubMedGoogle Scholar
  124. Zucker, M. B., Pert, J. H., and Hilgartner, M. W., 1966, Platelet function in a patient with thrombasthenia, Blood 28:524–534.PubMedGoogle Scholar
  125. Zucker, M. B., Kim, S. J., McPherson, J., and Grant, R. A., 1977, Binding of factor VIII to platelets in the presence of ristocetin, Br. J. Haematol. 35:535–549.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Alan T. Nurden
    • 1
  1. 1.Unité 150 INSERMHôpital LariboisièreParis, Cedex 10France

Personalised recommendations